From hospitals to biotech impact meets finance.
Key Drivers
Regulatory approvals.
R&D pipeline.
Patient outcomes.
Approaches
NPV for drug portfolios.
Comparable biotech multiples.
Way Forward:
Link innovation to commercial scale.
Long-term sustainability defines value.
Absolutely. We have IBBI-Registered Valuers under all three categories—Land & Building, Plant & Machinery, and Securities/Financial Assets. Our team also includes experienced chartered accountants and engineers.
Yes. We offer remote/desk-based valuation for startups, financial assets, and select use-cases. For physical assets, we usually require on-site verification.
Yes. Client confidentiality is paramount. All data shared is stored securely and not disclosed to any third party without your consent.